These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11092065)

  • 1. Bromocriptine reduces cigarette smoking.
    Jarvik ME; Caskey NH; Wirshing WC; Madsen DC; Iwamoto-Schaap PN; Elins JL; Eisenberger NI; Olmstead RE
    Addiction; 2000 Aug; 95(8):1173-83. PubMed ID: 11092065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating tobacco smoking rates by dopaminergic stimulation and blockade.
    Caskey NH; Jarvik ME; Wirshing WC; Madsen DC; Iwamoto-Schaap PN; Eisenberger NI; Huerta L; Terrace SM; Olmstead RE
    Nicotine Tob Res; 2002 Aug; 4(3):259-66. PubMed ID: 12215234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
    BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender effects on mood and cigarette craving during early abstinence and resumption of smoking.
    Xu J; Azizian A; Monterosso J; Domier CP; Brody AL; Fong TW; London ED
    Nicotine Tob Res; 2008 Nov; 10(11):1653-61. PubMed ID: 18988078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine use is associated with decreased smoking rates.
    Murphy MF; Hey K; Johnstone E; Munafo M; Walton R; Willis B; Harrison PJ
    Addict Biol; 2002 Jul; 7(3):325-8. PubMed ID: 12126493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials.
    Lobbezoo F; Soucy JP; Hartman NG; Montplaisir JY; Lavigne GJ
    J Dent Res; 1997 Sep; 76(9):1610-4. PubMed ID: 9294496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of smoking abstinence and chain-smoking on puffing topography and diurnal nicotine exposure.
    Kolonen S; Tuomisto J; Puustinen P; Airaksinen MM
    Pharmacol Biochem Behav; 1992 Jun; 42(2):327-32. PubMed ID: 1631188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cotinine on cigarette self-administration.
    Hatsukami D; Lexau B; Nelson D; Pentel PR; Sofuoglu M; Goldman A
    Psychopharmacology (Berl); 1998 Jul; 138(2):184-9. PubMed ID: 9718288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
    Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
    J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine for cocaine dependence. A controlled clinical trial.
    Handelsman L; Rosenblum A; Palij M; Magura S; Foote J; Lovejoy M; Stimmel B
    Am J Addict; 1997; 6(1):54-64. PubMed ID: 9097872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking history, cigarette yield and smoking behavior as determinants of smoke exposure.
    Bridges RB; Humble JW; Turbek JA; Rehm SR
    Eur J Respir Dis Suppl; 1986; 146():129-37. PubMed ID: 3465542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperprolactinemic amenorrhea:treatment with cabergoline versus bromocriptine. Results of a national multicenter randomized double-blind study].
    Pascal-Vigneron V; Weryha G; Bosc M; Leclere J
    Presse Med; 1995 Apr; 24(16):753-7. PubMed ID: 7784413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints.
    Adriaens K; Van Gucht D; Declerck P; Baeyens F
    Int J Environ Res Public Health; 2014 Oct; 11(11):11220-48. PubMed ID: 25358095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting smoking cessation. Who will quit with and without the nicotine patch.
    Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
    JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm.
    Rukstalis M; Jepson C; Strasser A; Lynch KG; Perkins K; Patterson F; Lerman C
    Psychopharmacology (Berl); 2005 Jun; 180(1):41-8. PubMed ID: 15682300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-quit depression level and smoking expectancies for mood management predict the nature of smoking withdrawal symptoms in college women smokers.
    Copeland AL; Kulesza M; Hecht GS
    Addict Behav; 2009 May; 34(5):481-3. PubMed ID: 19157715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.